文献速递血液净化与透析

渥太华声明在血液透析环境下整群随机试验的实施指导文件

The Ottawa Statement implementation guidance document for cluster randomized trials in the hemodialysis setting.
PubMed 文献 · Kidney Int · 2024-01-01

研究团队日益关注用整群随机试验(CRT)为维持性血液透析提供实践证据,但存在伦理复杂性。本文基于2012年渥太华声明的15条建议,联合内容专家与患者伙伴共同制定实施指导,帮助研究团队和伦理委员会将建议应用于透析场景。

要点

  • 渥太华声明含7个领域15条建议,需结合透析场景特点实施。
  • 该指导由内容专家与患者伙伴共同制定,历时4年研究项目。
  • 指导面向研究团队、伦理委员会及其他利益相关者。

核心结论

  • 本实施指导文件帮助将渥太华声明建议应用于血液透析环境下的整群随机试验。

研究设计与样本

  • 为期4年的研究项目,由内容专家和患者伙伴共同制定实施指导文件。

主要发现

  • 渥太华声明提出7个领域共15条建议以解决整群随机试验的伦理问题。
  • 将渥太华声明建议应用于血液透析场景因该环境和人群的独特特征而变得复杂。

关键数值与推荐

  • 渥太华声明的15条建议覆盖:论证CRT设计、研究伦理委员会审查、识别研究参与者、获取知情同意、把关人、评估受益与伤害、保护弱势参与者。

临床怎么用

  • 研究团队、研究伦理委员会及其他利益相关者可依据本文件在透析场景中应用渥太华声明建议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Research teams are increasingly interested in using cluster randomized trial (CRT) designs to generate practice-guiding evidence for in-center maintenance hemodialysis. However, CRTs raise complex ethical issues. The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials, published in 2012, provides 15 recommendations to address ethical issues arising within 7 domains: justifying the CRT design, research ethics committee review, identifying research participants, obtaining informed consent, gatekeepers, assessing benefits and harms, and protecting vulnerable participants. But applying the Ottawa Statement recommendations to CRTs in the hemodialysis setting is complicated by the unique features of the setting and population. Here, with the help of content experts and patient partners, we co-developed this implementation guidance document to provide research teams, research ethics committees, and other stakeholders with detailed guidance on how to apply the Ottawa Statement recommendations to CRTs in the hemodialysis setting, the result of a 4-year research project. Thus, our work demonstrates how the voices of patients, caregivers, and all stakeholders may be included in the development of research ethics guidance.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Goldstein CE, Taljaard M, Nicholls SG, et al. The Ottawa Statement implementation guidance document for cluster randomized trials in the hemodialysis setting. Kidney Int. 2024. PMID: 38642985. doi:10.1016/j.kint.2024.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。